Safety of an Escherichia coli-expressed bivalent human papillomavirus (types 16 and 18) L1 virus-like particle vaccine: an open-label phase I clinical trial.
about
A human monoclonal antibody against HPV16 recognizes an immunodominant and neutralizing epitope partially overlapping with that of H16.V5Recent progress in vaccination against human papillomavirus-mediated cervical cancer.Functional assessment and structural basis of antibody binding to human papillomavirus capsid.Escherichia coli-derived virus-like particles in vaccine development.
P2860
Safety of an Escherichia coli-expressed bivalent human papillomavirus (types 16 and 18) L1 virus-like particle vaccine: an open-label phase I clinical trial.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Safety of an Escherichia coli- ...... -label phase I clinical trial.
@ast
Safety of an Escherichia coli- ...... -label phase I clinical trial.
@en
Safety of an Escherichia coli-expressed bivalent human papillomavirus
@nl
type
label
Safety of an Escherichia coli- ...... -label phase I clinical trial.
@ast
Safety of an Escherichia coli- ...... -label phase I clinical trial.
@en
Safety of an Escherichia coli-expressed bivalent human papillomavirus
@nl
prefLabel
Safety of an Escherichia coli- ...... -label phase I clinical trial.
@ast
Safety of an Escherichia coli- ...... -label phase I clinical trial.
@en
Safety of an Escherichia coli-expressed bivalent human papillomavirus
@nl
P2093
P2860
P356
P1476
Safety of an Escherichia coli- ...... n-label phase I clinical trial
@en
P2093
Chang-Lin Yang
Feng-Cai Zhu
Han-Min Jiang
Hong-Jiang Huang
Jia-Ping Cai
Ning-Shao Xia
Shou-Jie Huang
P2860
P304
P356
10.4161/HV.26846
P50
P577
2013-10-25T00:00:00Z